Variant report
Variant | nsv947189 |
---|---|
Chromosome Location | chr1:84257762-84263159 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr1:84260072-84260370 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr1:84260088-84260453 | GM12878 | blood: | n/a | n/a |
3 | CEBPB | chr1:84262450-84262487 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | FOS | chr1:84257813-84257970 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr1:84257658-84258074 | MCF10A-Er-Src | breast: | n/a | chr1:84257682-84257693 |
6 | FOS | chr1:84257654-84258096 | MCF10A-Er-Src | breast: | n/a | chr1:84257682-84257693 |
7 | FOS | chr1:84257675-84258059 | MCF10A-Er-Src | breast: | n/a | chr1:84257682-84257693 |
8 | MYC | chr1:84257900-84257970 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr1:84260139-84260220 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | RUNX3 | chr1:84260156-84260462 | GM12878 | blood: | n/a | n/a |
11 | RUNX3 | chr1:84260084-84260457 | GM12878 | blood: | n/a | n/a |
12 | SPI1 | chr1:84260027-84260270 | GM12891 | blood: | n/a | n/a |
13 | STAT3 | chr1:84257711-84258082 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr1:84257657-84258097 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | STAT3 | chr1:84257672-84258086 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:84262652..84264184-chr1:84271934..84274320,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000223231 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370930379 | chr1:84257791-84257792 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs565611274 | chr1:84257833-84257834 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs189134315 | chr1:84257933-84257934 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs10782820 | chr1:84257951-84257952 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs375149166 | chr1:84257960-84257961 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs377539020 | chr1:84258060-84258061 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs12070852 | chr1:84258071-84258072 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs35811426 | chr1:84258091-84258092 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs563690632 | chr1:84258094-84258095 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs554536096 | chr1:84258100-84258101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556576530 | chr1:84258129-84258130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191955079 | chr1:84258178-84258179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576472558 | chr1:84258180-84258181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10159391 | chr1:84258181-84258182 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs139553324 | chr1:84258206-84258207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76386517 | chr1:84258241-84258242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541786458 | chr1:84258261-84258262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184562061 | chr1:84258318-84258319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532892771 | chr1:84258323-84258324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549520634 | chr1:84258379-84258380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563361682 | chr1:84258384-84258385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529001118 | chr1:84258417-84258418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549139709 | chr1:84258430-84258431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565574288 | chr1:84258439-84258440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534597258 | chr1:84258523-84258524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551311606 | chr1:84258556-84258557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571214649 | chr1:84258562-84258563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539783495 | chr1:84258567-84258568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556303037 | chr1:84258586-84258587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6699405 | chr1:84258609-84258610 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs187119431 | chr1:84258618-84258619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555985961 | chr1:84258624-84258625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191878742 | chr1:84258653-84258654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541646717 | chr1:84258661-84258662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560792463 | chr1:84258664-84258665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538113997 | chr1:84258684-84258685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564729840 | chr1:84258693-84258694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578198921 | chr1:84258697-84258698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543378139 | chr1:84258736-84258737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563166007 | chr1:84258739-84258740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184417247 | chr1:84258741-84258742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548710426 | chr1:84258746-84258747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189046718 | chr1:84258782-84258783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180996860 | chr1:84258809-84258810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551174102 | chr1:84258816-84258817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549324370 | chr1:84258853-84258854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557784321 | chr1:84258870-84258871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569311828 | chr1:84258878-84258879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs61243881 | chr1:84258881-84258882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs145131958 | chr1:84258967-84258968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:84255400-84264600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr1:84257000-84261600 | Weak transcription | Primary T cells from cord blood | blood |
3 | chr1:84257200-84258200 | Enhancers | NHDF-Ad | bronchial |
4 | chr1:84257200-84258400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr1:84257200-84258400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr1:84257400-84258000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr1:84257400-84258400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr1:84258000-84265000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr1:84258200-84265200 | Weak transcription | NHDF-Ad | bronchial |
10 | chr1:84261400-84264600 | Weak transcription | Gastric | stomach |
11 | chr1:84262000-84262200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr1:84262000-84262400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr1:84262000-84262600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr1:84262200-84262400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr1:84262200-84262400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr1:84262200-84262800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr1:84262200-84265400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr1:84262400-84264600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
19 | chr1:84262400-84265000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
20 | chr1:84262400-84265000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
21 | chr1:84262600-84265600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr1:84262800-84268800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |